Mechanisms of action of metformin with special reference to cardiovascular protection

Management guidelines continue to identify metformin as initial pharmacologic antidiabetic therapy of choice for people with type 2 diabetes without contraindications, despite recent randomized trials that have demonstrated significant improvements in cardiovascular outcomes with newer classes of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Zilov, Alexey V., Abdelaziz, Sulaf Ibrahim, AlShammary, Afaf, Al Zahrani, Ali, Amir, Ashraf, Assaad Khalil, Samir Helmy, Brand, Kerstin, Elkafrawy, Nabil, Hassoun, Ahmed A.K., Jahed, Adel, Jarrah, Nadim, Mrabeti, Sanaa, Paruk, Imran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851752/
https://www.ncbi.nlm.nih.gov/pubmed/31021474
http://dx.doi.org/10.1002/dmrr.3173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851752/
https://www.ncbi.nlm.nih.gov/pubmed/31021474
http://dx.doi.org/10.1002/dmrr.3173

Ejemplares similares